Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Expanded_access × Breast Neoplasms × Capecitabine × Clear all

Status

Approved for marketing 1

Sponsor Class

Study Type

Interventional 387 Observational 13 Expanded_access 1

Sponsor

Cancer Type

Conditions

Solid Tumors 1 Neoplasm Metastasis 1 HER2-positive Breast Cancer 1 Breast Neoplasms 1

Interventions

abemaciclib 2 Alpelisib 2 zenocutuzumab 1 tucatinib 1 selpercatinib 1 ribociclib 1 pegilodecakin 1 iniparib 1 eribulin 1 Proton Pump Inhibitors 1 Lapatinib 1 Hydrocortisone 1 Everolimus 1 Capecitabine 1 Ado-Trastuzumab Emtansine 1 AM0010 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00338247 2016-04-06

EAP (Expanded Access Protocol) Of Lapatinib Combined With Capecitabine In Metastatic Breast Cancer

Novartis

Approved for marketing

Breast Neoplasms, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡